Legal Representation
Attorney
John W. Crittenden
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 1, 2019 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 1, 2019 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Nov 27, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 2, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 2, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 12, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 24, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 23, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 10, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 5, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of Alzheimer's disease, Parkinson's disease, cancer, neurological disorders, oncological disorders, and age-associated disorders; biologic preparations for the treatment of Alzheimer's disease, Parkinson's disease, cancer, neurological disorders, oncological disorders, and age-associated disorders; pharmaceutical preparations for the treatment of neurodegenerative diseases and age-associated diseases; biologic preparations for the treatment of neurodegenerative diseases and age-associated diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Pharmaceutical and biologic research and development; consulting services in the field of research and development of pharmaceutical and biologic preparations; providing medical and scientific research information in the fields of pharmaceuticals and biologics
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042